Contrast Enhanced Breast MRI: Comparison of Two Macrocyclic Gadolinium-Based Contrast Agents: Gadoterate Meglumine (Dotarem) and Gadobutrol (Gadavist). A Prospective Study
Latest Information Update: 07 Apr 2025
At a glance
- Drugs Gadobutrol (Primary) ; Gadoterate-meglumine
- Indications Breast disorders
- Focus Diagnostic use
- 02 Apr 2025 Planned primary completion date changed from 1 Mar 2025 to 1 Jul 2025.
- 19 Apr 2024 Planned End Date changed from 1 Mar 2025 to 1 Mar 2026.
- 19 Apr 2024 Planned primary completion date changed from 1 Mar 2024 to 1 Mar 2025.